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Abstract
Governance in health is cited as one of the key factors in balancing the concerns of the government and public 
sector with the interests of civil society/private players, but often remains poorly described and operationalized. 
Richard Saltman and Antonio Duran look at two aspects in the search for new provider models in a context of 
health markets signalling liberalisation: (i) the role of the government to balance public and private interests 
and responsibilities in delivering care through modernised governance arrangements, and (ii) the finding that 
operational complexities may hinder well–designed provider governance models, unless governance reflects 
country-specific realities. This commentary builds on the discussion by Saltman and Duran, and argues that the 
concept of governance needs to be clearly defined and operationalized in order to be helpful for policy debate 
as well as for the development of an applicable framework for performance improvement. It provides a working 
definition of governance and includes a reflection on the prevailing cultural norms in an organization or society 
upon which any governance needs to be build. It proposes to explore whether the “evidence-based governance” 
concept can be introduced to generate knowledge about innovative and effective governance models, and 
concludes that studies similar to the one by Saltman and Duran can inform this debate. 
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Governance is a priority area in the move towards achieving universal healthcare as well as improving quality, efficiency, effectiveness, and responsiveness 
of health systems. Mechanisms of establishing good 
governance practice and measuring its impact has been an 
issue of ongoing debates with some commentators focusing 
on structures, while others preferring to concentrate on the 
health outcomes.1 This commentary continues the discussion 
brought up by Saltman and Duran,2 expands on the definition 
of governance, and adds some thoughts on governance in 
health.
Richard Saltman and Anonio Duran examine some of the 
main operational complexities of provider governance, 
while discussing governance efforts targeting health service 
providers. They start from the notion that in a number 
of countries the role of the state has started to change with 
focussing more on governing (private) providers rather 
than directly providing services. These changes generated 
the need to revisit governance arrangements in an altered 
service delivery landscape, with the introduction of market-
like incentives and management structures, as well as non-
state actors attaining an important role alongside with public 
entities.2 
The authors use the framework developed by Duran and 
colleagues3 which identifies governance in the health sector 
at the three levels of macro (national, policy-making), meso 
(institutional), and micro (operational at provider level), to 
examine challenges and suggest mitigation solutions at these 
levels that might ideally complement specific management 
techniques for effective service delivery practices.
Saltman and Duran look at tax-based systems, where 
governments have – in a somewhat secular trend – gradually 
pulled out of direct service provision and focussed on 
governing the more independent providers of care, recognising 
that the engagement of non-governmental actors require 
regulations about minimum standards on quality and access 
and allowing to compete in a fair environment. The authors 
confine their analysis to the meso-level governance, described 
as “[a] set of processes and tools related to decision-making in 
steering the totality of institutional activity, influencing most 
major aspects of organizational behavior and recognizing the 
complex relationships between multiple stakeholders. Its scope 
ranges from normative values (equity, ethics) to access, quality, 
patient responsiveness, and patient safety dimensions. It also 
incorporates political, financial, managerial as well as daily 
operational issues.”3
The authors describe emerging (innovative) provider models 
and use the example of England to indicate that complicated 
public sector contracting rules are a substantial barrier for 
market entry. Saltman and Duran then review the cases of 
Sweden (with new providers and governance structures 
in primary healthcare) and Spain (with different hospital 
governance models) and show the inherent complexity 
involved in developing new public and mixed public-private 
provider models. They rightly conclude that good governance 
in healthcare will need to reflect a country’s practical and 
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political experiences at the ground level.
What Is Governance? 
Looking at the discussion on governance, two strands of 
thinking emerge: (i) governance derives from a broad ethical 
and philosophical debate within society leading to values and 
cultures in an organization,4 and forms the basis for more 
specific management discussions on how to organize and 
steer service providers to achieve broader health systems 
objectives; and (ii) governance is used as a kind of place-
holder for describing the need/willingness for “doing a better 
job,” thus allowing for grand aims, but sometimes leaving 
the processes and targets rather vague, thus ultimately non-
enforceable.
Definitions of “governance” are often broad and 
encompassing,5 making it difficult to use them. This is 
sometimes compounded by compounding political aspects 
and vague separation of governance and management.
The World Health Organization (WHO) defines governance 
(sometimes called “stewardship”) in the health sector as “a 
wide range of steering and rule-making related functions 
carried out by governments/decisions-makers, as they 
seek to achieve national health policy objectives that are 
conducive to universal health coverage” (http://www.who.int/
healthsystems/topics/stewardship/en/).
“By ‘governance,’ we mean all ‘steering’ carried out by public 
bodies that seeks to constrain, encourage or otherwise 
influence acts of private and public parties. This includes 
structures that ‘delegate’ the steering capacity to non-public 
bodies (ie, professional associations). By ‘steering,’ we 
mean to include binding regulatory measures (laws) and 
other measures that are sometimes called ‘new governance’ 
measures – that is, ‘a range of processes and practices that 
have a normative dimension but do not operate primarily or 
at all through the formal mechanism of traditional command-
and-control-type legal institutions.’”6 
Governance for present purposes is defined as “the structures 
and processes by which the health system is regulated, 
directed and controlled.”7 
Savedoff has identified five dimensions of governance as 
it has been used widely for governments, corporations, 
and financial markets: (i) Coherent decision-making 
structures, (ii) Stakeholder participation, (iii) Transparency 
and information, (iv) Supervision and regulation and (v) 
Consistency and stability.8 
There remains much debate on the concept of Governance and 
the different approaches to its definition, most notably related 
to the issue of shared cultural values and norms. Governance 
concepts cannot be transferred, they need to be built on what 
is culturally appropriate. In 1971, the American philosopher 
John Rawls coined the term “reflective equilibrium” to denote 
“a state of balance or coherence among a set of beliefs arrived at 
by a process of deliberative mutual adjustment among general 
principles and particular judgments.”9 In practical terms, 
reflective equilibrium is about how to identify and resolve 
logical inconsistencies in the prevailing moral compass of a 
group or society and eventually develop its moral structure.
Extending the concept of Greer and colleagues,10 we suggest 
to define governance as “The culturally appropriate rules, 
processes and institutions through which decisions are made 
and authority is exercised in order to achieve transparency, 
accountability, participation, integrity, and capacity.”
Extending Governance Debate Beyond Healthcare Provider 
Governance
For better understanding the challenges in governing 
healthcare providers, it is useful to extend the governance 
debate beyond the service provider models to health financing 
and funding structures11 (amongst many other aspects like 
pharmaceuticals, teaching, research, etc). This aspects had 
been deliberately left out by Saltman and Duran, while 
acknowledging their importance. 
Regardless of how funds are collected and pooled, any publicly 
organized financing scheme faces the challenge of “prudent 
purchasing,”12 ie, how to spend the available means in a way 
that satisfies concerns around responsiveness, quality, equity 
and efficiency while preserving clinical autonomy and 
allowing for developing innovative forms of diagnosis and 
treatment. Governing fund pooling, resource allocation, 
health service purchasing, together with health service 
provision is an important element in achieving such critical, 
and, at times, conflicting aims.
There is an intense debate about how a governance model for 
providers might look like.8 We strongly believe the prevailing 
logic of neoliberalism with its promise of more efficiency 
and stipulating a major role for market-oriented healthcare 
does not mean to leave the markets alone but rather requires 
strong governance arrangements. Focussing on efficiency 
and treating the patient as a customer has an important role 
in many standard healthcare encounters, especially those 
which are non-acute and non-life-threatening – a fact that the 
medical profession still struggles to accept. It is here, where 
approaches like “performance-based payments” might be put 
to a good use.13 Where appropriate (and measurable), paying 
for high quality care can help in developing a culture of 
quality and fostering innovation and collaboration. However, 
effectiveness, empathy and professional dedication remains 
a non-substitutable priority in case of emergency and acute 
care, assigning cost-savings a lower priority. This is where 
market forces can be destructive. Appeals only to the rational 
“economic man” within the clinician and fostering self-
interest by paying bonuses for achieving targets might actually 
damage the motivational fabric of those providing care and 
finding reward from being intrinsically motivated.13 If I pay 
a doctor for immunizing children but not for counselling the 
mothers, I will affect the way this doctor is allocating his time, 
disconcerting health outcomes.
Evidence-Based Governance?
Given these challenges, the idea of “evidence-based health 
policy” should be brought into the governance debate. 
The idea is coined after the approach of “evidence-based 
medicine,” described by David Sackett as “the conscientious, 
explicit and judicious use of current best evidence in making 
decisions about the care of individual patients.”14 The concept 
of combining best available evidence, clinical experience and 
patient preferences is based on identifying, disseminating, 
and, most importantly, applying research that is properly 
conducted and clinically relevant. 
Jeffery Pfeffer and Robert Sutton promoted the idea of 
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“evidence-based management” 10 years ago, as they saw 
similarities between clinical and management decision-
making.15 “The same behaviour [of doctors] holds true for 
managers looking to cure their organizational ills. Indeed, we 
would argue, managers are actually much more ignorant than 
doctors about which prescriptions are reliable—and they’re less 
eager to find out.”
Taking this idea just a little step further, there is an argument 
to base governance on such a pragmatic approach of “what 
works, what does not and why?”16 However, the complexity 
of the governance concept, the number of actors involved 
at different levels, and the multiplicity of scenarios that 
can develop in a diverse context makes such an approach 
challenging.17 
Still, evidence-based models of governance might create 
a platform for sharing useful instruments and different 
accountability arrangements, and point to new roles for 
various layers of the society in accelerating health system 
outcomes. Eg, the involvement of civil society organizations 
like patient associations or provider associations have a lot 
to contribute to health governance as does the astute use of 
(routine) data. Twenty-first century health governance has 
the challenge to find ways to make meaningful use of them in 
a way that dovetails with cultural norms.
The Way Forward
Governance, similar to other encompassing terms like 
“management” or “quality,” needs to be succinctly defined 
and operationalized in order to become meaningful and 
useful.8 Nowadays the connotation of governance has been 
broadened, as it is no longer “regarded as one – way traffic 
from those governing to those governed,”5 and multiple new 
actors have entered the political arena18; “the government 
is hardly anymore the most powerful actor in the policy 
arena.”19 Moretti and Pestre show in their linguistic analysis 
of World Bank reports, how the use of the term “governance” 
has evolved since 1990, unilaterally tilted towards being 
“good governance” (italics added) and having ethical claims 
attached to it.20 In order to attain such good governance, it 
is hard to overstate the benefits to an organization of a clear 
sense of mission that will allow its staff to focus on delivering 
it. A often missed argument in favour of establishing a 
new and independent health financing organization is just 
this importance of having a clear mission and being held 
accountable for achieving it. 
Good governance models should set a balance between being 
specific enough to guide management in producing the best 
attainable results while reflecting institutional values, and 
permitting a leeway for managers to be creative in countering 
unforeseeable needs and circumstances. They have to be 
rooted in understanding and reacting on the predominant 
culture of a system or an organization upon which to build 
on, at the same time incorporating (at least to some extent) 
the prevailing cultural values and norms of a society. 
Good governance models should try to attain such a balance by 
using a solid evidence-base, by setting transparent processes, 
and by bringing in relevant work practices, structures and 
technologies enabling the application of lessons learnt.
Nevertheless, we believe that a good governance also requires 
a mind-set, which acknowledges “that true wisdom does not 
come from the sheer accumulation of knowledge, but from 
a healthy respect for and curiosity about the vast realms of 
knowledge still unconquered.”15 It is a fair point to reflect 
whether such pragmatism and humbleness might be at odds 
with the technical rigidity of generating “evidence.” At any rate, 
studies like this one by Richard Saltman and Antonio Duran 
contribute to the systematic understanding of governance and 
help building up an joint understanding and empirical base 
for good governance in healthcare.
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